Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation

International Journal of Antimicrobial Agents

Volumn 35, Issue 2, 2010, Pages 126-130

  Liaw, S J ^a,b   Lee, Y L ^a   Hsueh, P R ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Biofilm formation; Efflux pumps; Integrons; Melanin; Multidrug resistance; Phosphoglucomutase (SpgM); Stenotrophomonas maltophilia

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CARRIER PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EFFLUX PUMP; GENTAMICIN; LEVOFLOXACIN; MELANIN; MEROPENEM; PHOSPHOGLUCOMUTASE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; ENZYME MODIFICATION; GENE CASSETTE; GENE FREQUENCY; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; TAIWAN;

BACTERIAL PROTEINS; BIOFILMS; BIOLOGICAL TRANSPORT, ACTIVE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION PROFILING; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTEGRONS; MELANINS; PHOSPHOGLUCOMUTASE; SEQUENCE ANALYSIS, DNA; STENOTROPHOMONAS MALTOPHILIA; TAIWAN;

EID: 72449135236     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.09.015     Document Type: Article

References (33)

1. Chang L.L., Chen H.F., Chang C.Y., Lee T.M., and Wu W.J. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 53 (2004) 518-521
2. Liaw S.J., Teng L.J., Hsueh P.R., Ho S.W., and Luh K.T. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia. J Formos Med Assoc 101 (2002) 495-501
3. Tan C.K., Liaw S.J., Yu C.J., Teng L.J., and Hsueh P.R. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis 60 (2008) 205-210
4. Denton M., and Kerr K.G. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11 (1998) 57-80
5. Li X.Z., Zhang L., and Poole K. SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 46 (2002) 333-343
6. Zhang L., Li X.Z., and Poole K. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45 (2001) 3497-3503
7. McKay G.A., Woods D.E., MacDonald K.L., and Poole K. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun 71 (2003) 3068-3075
8. Gould V.C., and Avison M.B. SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 57 (2006) 1070-1076
9. Crossman L.C., Gould V.C., Dow J.M., Vernikos G.S., Okazaki A., Sebaihia M., et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9 (2008) R74
10. Chang Y.C., Shih D.Y., Wang J.Y., and Yang S.S. Molecular characterization of class 1 integrons and antimicrobial resistance in Aeromonas strains from foodborne outbreak-suspect samples and environmental sources in Taiwan. Diagn Microbiol Infect Dis 59 (2007) 191-197
11. Gu B., Tong M., Zhao W., Liu G., Ning M., Pan S., et al. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J Clin Microbiol 45 (2007) 241-243
12. Jones M.E., Peters E., Weersink A.M., Fluit A., and Verhoef J. Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria. Lancet 349 (1997) 1742-1743
13. Claus H. Laccases and their occurrence in prokaryotes. Arch Microbiol 179 (2003) 145-150
14. Di Bonaventura G., Spedicato I., D'Antonio D., Robuffo I., and Piccolomini R. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 48 (2004) 151-160
15. Gomez B.L., and Nosanchuk J.D. Melanin and fungi. Curr Opin Infect Dis 16 (2003) 91-96
16. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. Document M7-A6. Wayne, PA: CLSI; 2005.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Supplemental Tables, M100-S18. Wayne, PA: CLSI; 2008.
18. Ploy M.C., Denis F., Courvalin P., and Lambert T. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother 44 (2000) 2684-2688
19. Kado C.I., and Liu S.T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145 (1981) 1365-1373
20. Meadus W.J. A semi-quantitative RT-PCR method to measure the in vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expression. Biol Proced Online 5 (2003) 20-28
21. Wang G., Aazaz A., Peng Z., and Shen P. Cloning and overexpression of a tyrosinase gene mel from Pseudomonas maltophila. FEMS Microbiol Lett 185 (2000) 23-27
22. Gould V.C., Okazaki A., Howe R.A., and Avison M.B. Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates. J Antimicrob Chemother 54 (2004) 348-353
23. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178 (1996) 5853-5859
24. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264 (1994) 382-388
25. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 10 (2004) 12-26
26. Martinez-Freijo P., Fluit A.C., Schmitz F.J., Grek V.S., Verhoef J., and Jones M.E. Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 42 (1998) 689-696
27. Yan J.J., Ko W.C., Chuang C.L., and Wu J.J. Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J Antimicrob Chemother 50 (2002) 503-511
28. IMP-8 in a university medical center in Taiwan. J Clin Microbiol 39 (2001) 4433-4439
29. Barbolla R., Catalano M., Orman B.E., Famiglietti A., Vay C., Smayevsky J., et al. Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother 48 (2004) 666-669
30. Toleman M.A., Bennett P.M., Bennett D.M., Jones R.N., and Walsh T.R. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 13 (2007) 559-565
31. Gaze W.H., Abdouslam N., Hawkey P.M., and Wellington E.M.H. Incidence of class 1 integrons in a quaternary ammonium compound-polluted environment. Antimicrob Agents Chemother 49 (2005) 1802-1807
32. Sanchez P., Moreno E., and Martinez J.L. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 49 (2005) 781-782
33. Coyne V.E., and al-Harthi L. Induction of melanin biosynthesis in Vibrio cholerae. Appl Environ Microbiol 58 (1992) 2861-2865